314 related articles for article (PubMed ID: 23385376)
1. How to manage Waldenstrom's macroglobulinemia.
Buske C; Leblond V
Leukemia; 2013 Apr; 27(4):762-72. PubMed ID: 23385376
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
Kyle RA; Ansell SM; Kapoor P
Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
[TBL] [Abstract][Full Text] [Related]
3. How to manage waldenström's macroglobulinemia in 2024.
Grunenberg A; Buske C
Cancer Treat Rev; 2024 Apr; 125():102715. PubMed ID: 38471356
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
5. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
6. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Dogliotti I; Jiménez C; Varettoni M; Talaulikar D; Bagratuni T; Ferrante M; Pérez J; Drandi D; Puig N; Gilestro M; García-Álvarez M; Owen R; Jurczak W; Tedeschi A; Leblond V; Kastritis E; Kersten MJ; D'Sa S; Kaščák M; Willenbacher W; Roccaro AM; Poulain S; Morel P; Kyriakou C; Fend F; Vos JMI; Dimopoulos MA; Buske C; Ferrero S; García-Sanz R
Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884
[TBL] [Abstract][Full Text] [Related]
7. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
8. Waldenstrom's macroglobulinemia in the era of immunotherapy.
Vaxman I; Gertz M
Leuk Lymphoma; 2020 Jun; 61(6):1292-1304. PubMed ID: 31960730
[TBL] [Abstract][Full Text] [Related]
9. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
Jalali S; Ansell SM
Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460
[TBL] [Abstract][Full Text] [Related]
11. Waldenström's macroglobulinemia.
Dimopoulos MA; Anagnostopoulos A
Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
[TBL] [Abstract][Full Text] [Related]
12. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
[TBL] [Abstract][Full Text] [Related]
13. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia.
Vos JM; Minnema MC; Wijermans PW; Croockewit S; Chamuleau ME; Pals ST; Klein SK; Delforge M; van Imhoff GW; Kersten MJ; ;
Neth J Med; 2013 Mar; 71(2):54-62. PubMed ID: 23462052
[TBL] [Abstract][Full Text] [Related]
14. Simple headache revealed a rare lymphoma: Waldenstrom macroglobulinemia with unique markers: a case report and review of the literature.
Awad AK; Elbadawy MA; Boury M; Rivera A; Motawea K; Shah J; Parnia S; Varney J
J Egypt Natl Canc Inst; 2022 Mar; 34(1):10. PubMed ID: 35253074
[TBL] [Abstract][Full Text] [Related]
15. A review of Waldenstrom's macroglobulinemia.
McDermott MK; Bell EM
Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
[TBL] [Abstract][Full Text] [Related]
16. Managing complications secondary to Waldenström's macroglobulinemia.
Pessach I; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2021 Jul; 14(7):621-632. PubMed ID: 34170207
[No Abstract] [Full Text] [Related]
17. Waldenstrom's macroglobulinemia.
Singhal N; Bapsy PP; Babu KG; Sahoo TP
J Assoc Physicians India; 2004 Dec; 52():981-5. PubMed ID: 15884458
[TBL] [Abstract][Full Text] [Related]
18. Waldenström's macroglobulinemia as a diagnostic challenge: case report.
Budimir I; Nikolić M; Pusić MS; Hrabar D; Ljubicić N; Duvnjak M; Supanc V; Nikolac I; Babić N; Sokcević M
Acta Clin Croat; 2014 Mar; 53(1):94-7. PubMed ID: 24974671
[TBL] [Abstract][Full Text] [Related]
19. [How can we treat Waldenström's macroglobulinemia?].
Mucsi AO; Nagy Z
Magy Onkol; 2017 Mar; 61(1):12-20. PubMed ID: 28273184
[TBL] [Abstract][Full Text] [Related]
20. Blurry Vision as a Presentation of Waldenström's Macroglobulinemia: A Case Report With Review of Current Management.
Adams TN; Jetly-Shridhar R; Tran D; Boulmay BC
J Investig Med High Impact Case Rep; 2022; 10():23247096211052187. PubMed ID: 35258381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]